[Effect of anabolic steroids on skeletal bone differentiation in hypophyseal and cerebral (hypothalamic) nanism].
D000293:Adolescent; D000328:Adult; D000365:Age Determination by Skeleton; D045930:Anabolic Agents / Q000627:therapeutic use*; D001846:Bone Development / Q000187:drug effects*; D002648:Child; D002675:Child, Preschool; D004392:Dwarfism / Q000000981:diagnostic imaging / Q000188:drug therapy*; D004393:Dwarfism, Pituitary / Q000000981:diagnostic imaging / Q000188:drug therapy*; D005260:Female; D005542:Forearm / Q000000981:diagnostic imaging; D006225:Hand / Q000000981:diagnostic imaging; D006801:Humans; D007027:Hypothalamic Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy; D007031:Hypothalamus; D007223:Infant; D008297:Male; D008696:Methandrostenolone / Q000627:therapeutic use; D009277:Nandrolone / Q000627:therapeutic use*; D009999:Ossification, Heterotopic / Q000000981:diagnostic imaging / Q000188:drug therapy; D010012:Osteogenesis / Q000187:drug effects; D013997:Time Factors
D045930:Anabolic Agents; D009277:Nandrolone; D008696:Methandrostenolone
Vliianie anabolicheskikh steroidov na differentsirovku kosteĭ skeleta pri gipofizarnom i tserebral'nom (gipotalamicheskom) nanizme